Please note: The information posted was accurate at the time of posting but may be superseded by subsequent news releases.
Click here to subscribe (unsubscribe) to news releases from Afexa Life Sciences Inc. by email2011 |  2010 |  2009 |  2008 |  2007 |  2006 |  2005 |  2004 |  2003 |  2002 |  2000 |  
EDMONTON, ALBERTA--(Marketwire - 12 déc. 2011) - Afexa Life Sciences Inc. (« Afexa » ou la « Société ») (TSX:FXA)...
print release
EDMONTON, ALBERTA--(Marketwire - Dec. 12, 2011) - Afexa Life Sciences Inc. ("Afexa" or the "Company") (TSX:FXA) announced today that at its special meeting of shareholders held...
print release
pdf
EDMONTON, ALBERTA--(Marketwire - 16 nov. 2011) - Afexa Life Sciences Inc. (« Afexa » ou la « Société ») (TSX:FXA) a annoncé...
print release
pdf
EDMONTON, ALBERTA--(Marketwire - Nov. 16, 2011) - Afexa Life Sciences Inc. ("Afexa" or the "Company") (TSX:FXA) announced today that it has mailed to its...
print release
pdf
EDMONTON, ALBERTA--(Marketwire - Nov. 11, 2011) - Afexa Life Sciences Inc. ("Afexa" or the "Company") (TSX:FXA) today announced that during the quarter ended September 30, 2011 revenue of $15.0 million was achieved,...
print release
pdf
EDMONTON, ALBERTA--(Marketwire - Oct. 27, 2011) - Afexa Life Sciences Inc. ("Afexa" or the "Company") (TSX:FXA) - the maker of COLD-FX® - announced today that it has been advised...
print release
pdf
EDMONTON, ALBERTA--(Marketwire - Oct. 18, 2011) - Afexa Life Sciences Inc. ("Afexa" or the "Company") (TSX:FXA) - the maker of COLD-FX® - announced today that Robert Chai-Onn, Executive Vice President,...
print release
pdf
EDMONTON, ALBERTA--(Marketwire - Oct. 18, 2011) - Afexa Life Sciences Inc. ("Afexa" or the "Company") (TSX:FXA) - the maker of COLD-FX® - announced today that it has been advised by 1625907 Alberta Ltd. (the "Offeror"), a...
print release
pdf
EDMONTON, ALBERTA--(Marketwire - Oct. 4, 2011) - Afexa Life Sciences Inc. ("Afexa" or the "Company") (TSX:FXA) - the maker of COLD-FX® - announced today that it has filed a notice...
print release
pdf
EDMONTON, ALBERTA--(Marketwire - Sept. 30, 2011) - Afexa Life Sciences Inc. ("Afexa" or the "Company") (TSX:FXA) - the maker of COLD-FX® - announced today that it has entered...
print release
pdf
EDMONTON, ALBERTA--(Marketwire - Sept. 28, 2011) - Afexa Life Sciences Inc. ("Afexa" or the "Company") (TSX:FXA) - the maker of COLD-FX® - announced today that Paladin Labs Inc. ("Paladin") has amended...
print release
pdf
EDMONTON, ALBERTA--(Marketwire - Sept. 22, 2011) - Afexa Life Sciences Inc. ("Afexa" or the "Company") (TSX:FXA) - the maker of COLD-FX® - responded to a news release issued today...
print release
pdf
EDMONTON, ALBERTA--(Marketwire - Sept. 9, 2011) - Afexa Life Sciences Inc. ("Afexa" or the "Company") (TSX:FXA) - the maker of COLD-FX® - today announced that its Board of...
print release
pdf
KINGSTON, ONTARIO--(Marketwire - Sept. 6, 2011) -
Attention medical writers/reporters; business reporters; education reporters
Queen's University medical researchers today released the first report of its...
print release
pdf
TORONTO, ONTARIO--(Marketwire - Aug. 31, 2011) -
Attention: Medical and Business Editors
Afexa Life Sciences Inc.("Afexa" or the "Company") (TSX:FXA) today officially launched...
print release
pdf
EDMONTON, ALBERTA--(Marketwire - Aug. 30, 2011) - Afexa Life Sciences Inc. ("Afexa" or the "Company") (TSX:FXA)- the maker of COLD-FX®- today announced that it has entered into a definitive acquisition support agreement...
print release
pdf
EDMONTON, ALBERTA--(Marketwire - Aug. 26, 2011) - Afexa Life Sciences Inc. (TSX:FXA) today announced the encouraging results of an interim analysis performed by an independent data monitoring committee (IDMC) for the...
print release
pdf
EDMONTON, ALBERTA--(Marketwire - Aug. 23, 2011) - Afexa Life Sciences Inc. ("Afexa" or the "Company") (TSX:FXA) - the maker of COLD-FX® - today announced that its Board of Directors (the "Board")...
print release
pdf
EDMONTON, ALBERTA--(Marketwire - Aug. 19, 2011) -
- First quarter results improve over last year
- Product...
print release
pdf
EDMONTON, ALBERTA--(Marketwire - Aug. 18, 2011) - Afexa Life Sciences Inc. ("Afexa" or the "Company") (TSX:FXA) - the maker of COLD-FX® - today announced promising results of a pilot clinical study...
print release
pdf
EDMONTON, ALBERTA--(Marketwire - Aug. 17, 2011) - Afexa Life Sciences Inc. ("Afexa" or the "Company") (TSX:FXA) - the maker of COLD-FX® - announces that it has been notified by...
print release
pdf
EDMONTON, ALBERTA--(Marketwire - Aug. 14, 2011) - Afexa Life Sciences Inc. ("Afexa" or the "Company") (TSX:FXA) - the maker of COLD-FX® - has adopted a new shareholder rights plan (the "New Rights Plan"). The New...
print release
pdf
EDMONTON, ALBERTA--(Marketwire - Aug. 10, 2011) - Afexa Life Sciences Inc. ("Afexa" or "the Company") (TSX:FXA) outlined today at their shareholders Annual General Meeting ("AGM") the progress the Company is making towards...
print release
pdf
EDMONTON, ALBERTA--(Marketwire - Aug. 10, 2011) - Afexa Life Sciences Inc. ("Afexa" or the "Company") (TSX:FXA) - the maker of COLD-FX(R) – was today advised that Paladin Labs Inc. ("Paladin") has filed documents with Canadian...
print release
pdf
EDMONTON, ALBERTA--(Marketwire - July 18, 2011) - Afexa Life Sciences Inc. (TSX:FXA) today announced the U.S. Food and Drug Administration (FDA) authorization of a Phase 1B clinical trial of AFX-2 (CVT-E002™) as an...
print release
pdf
EDMONTON, ALBERTA--(Marketwire - July 18, 2011) - Afexa Life Sciences Inc. (TSX:FXA)
On Friday, July 15, 2011, after market close, Paladin Labs Inc. announced in a news release that they had purchased 14.94% of Afexa's...
print release
pdf
EDMONTON, ALBERTA--(Marketwire - June 24, 2011) - Afexa Life Sciences Inc. ("Afexa" or the "Company") (TSX:FXA) - the maker of COLD-FX® – today announced that the Human Resources and Compensation Committee of the...
print release
pdf
EDMONTON, ALBERTA--(Marketwire - June 23, 2011) - Afexa Life Sciences Inc. ("Afexa" or the "Company") (TSX:FXA), maker of COLD-FX®, announced the appointment of Annalisa King, Senior Vice President and CFO of Best...
print release
pdf
EDMONTON, ALBERTA--(Marketwire - June 10, 2011) - Afexa Life Sciences Inc. ("Afexa" or "the Company") (TSX:FXA) today announced its financial results for the year ended March 31, 2011.
EDMONTON, ALBERTA--(Marketwire - June 2, 2011) - Afexa Life Sciences Inc. (TSX:FXA) - the maker of COLD-FX® – today announced results of a clinical trial exploring the potential application of...
print release
pdf
EDMONTON, ALBERTA--(Marketwire - March 31, 2011) - Afexa Life Sciences Inc. ("Afexa" or the "Company") (TSX:FXA) today announced the appointment of William B. White as Independent Chairman of the Board of Directors of Afexa, effective...
print release
pdf
EDMONTON, ALBERTA--(Marketwire - Feb. 11, 2011) - Afexa Life Sciences Inc. ("Afexa" or "the Company") (TSX:FXA) today announced its financial results for the three months ended December 31, 2010.
...EDMONTON, ALBERTA--(Marketwire - Jan. 21, 2011) - Afexa Life Sciences Inc. ("Afexa" or the "Company") (TSX:FXA), maker of COLD-FX, announced that Ms. Tracey Ramsay has agreed to join the Company,...
print release
pdf
EDMONTON, ALBERTA--(Marketwire - Jan. 19, 2011) - Afexa Life Sciences Inc. ("Afexa") (TSX:FXA) wishes to set the record straight. After a thorough review of our contractual arrangements and other dealings with Alberta Health...
print release
pdf
Contact Us | Legal Terms & Conditions | Privacy Policy | Site Map | Français© Afexa Life Science Inc. (2006-2010) All rights reserved.
TM / ® owned by Afexa Life Science Inc. unless otherwise marked
This website is not intended for residents of the United States.